advertiser banner advertiser banner
Digital Issues

Home >  News >  June, 2014

FDA Says More Decisions on Morcellation Coming

The agency will hold a public meeting in July.

Published: June 12, 2014

Will morcellation devices used to laparoscopically remove uterine fibroids be recalled or banned? The FDA is convening a meeting next month to take up the topic.

The agency issued an advisory in April, discouraging their use because the devices can spread cancerous tissue in women with undetected uterine sarcomas, a condition the agency says may affect as many as 1 in every 350 women.

However, proponents of morcellation say the proportion of women with undetected sarcomas is likely closer to 1 in 1,000; that the prognosis is already bleak for those women; and that for everyone else, the alternatives are typically much more dangerous and invasive.

The FDA's Medical Devices Advisory Committee will hold a public meeting on July 10 and 11 and plans to "make recommendations regarding the appropriate use, premarket testing, labeling, and other risk mitigations" for morcellators.

One stock analyst, Greg Chodaaczek of Sterne Agee, says the meeting is likely to result in a so-called black-box warning, saying he doesn't think there's enough data to warrant a recall or ban.

Jim Burger


Also in the News...

Wrongly Connected Tubing a Major Concern, Says Joint Commission
Change Coming to GI Centers' Payment Models
Black Box Recorder On Its Way
Drug Mix-Up Blinds Patient, Spurs Malpractice Verdict
Doctor Fined $2,500 for Trigger Release Gaffe
At More Than $200K a Year, Surgeons Are Highest Earners
Drug Maker Introduces 10 mL Propofol

 
Have an account? Please log in:
Email Address:
  Remember my login on this computer

DID YOU SEE THIS?
Video and Imaging Equipment

Managing Surgical Images Just Got Easier

advertiser banner

Other Articles That May Interest You

Medical and Legal Relief for OR Nurse

Missouri court upholds award after nurse's OR fall and treatment ordeal.

Are Spine Surgeons Profiting From Supply Preferences?

Federal investigation sounds warning on spinal implants' physician-owned distributors.

R.I. Hospital Pays $500,000 to Settle Stark Claims

Investigators cited 9 improper hospital-doctor arrangements